AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 89 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $32,126,000 | +47.9% | 536,873 | -30.6% | 0.04% | +17.6% |
| Q3 2019 | $21,721,000 | +10.7% | 773,279 | +49.2% | 0.03% | +17.2% |
| Q2 2019 | $19,619,000 | -29.3% | 518,193 | -27.1% | 0.03% | -31.0% |
| Q1 2019 | $27,736,000 | +120.1% | 710,809 | +20.3% | 0.04% | +110.0% |
| Q4 2018 | $12,600,000 | -2.2% | 590,974 | +75.3% | 0.02% | +17.6% |
| Q2 2018 | $12,879,000 | +102.8% | 337,055 | +59.5% | 0.02% | +112.5% |
| Q1 2018 | $6,351,000 | +87.0% | 211,348 | +74.3% | 0.01% | +60.0% |
| Q3 2017 | $3,397,000 | -2.1% | 121,275 | -33.1% | 0.01% | -16.7% |
| Q2 2017 | $3,470,000 | +135.6% | 181,370 | +109.8% | 0.01% | +100.0% |
| Q1 2017 | $1,473,000 | -8.1% | 86,437 | -1.5% | 0.00% | 0.0% |
| Q4 2016 | $1,603,000 | – | 87,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
| Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
| Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
| Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
| Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
| Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
| Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
| Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
| Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |